Targeting Epidermal Growth Factor Receptors in Recurrent Glioblastoma Via a Novel Epithelial Growth Factor Receptor-Conjugated Nanocell Doxorubicin Delivery System

Neurosurgery. 2018 Mar 1;82(3):N23-N24. doi: 10.1093/neuros/nyx594.
No abstract available